vs

Side-by-side financial comparison of Surgery Partners, Inc. (SGRY) and SouthState Bank Corp (SSB). Click either name above to swap in a different company.

Surgery Partners, Inc. is the larger business by last-quarter revenue ($885.0M vs $661.7M, roughly 1.3× SouthState Bank Corp). SouthState Bank Corp runs the higher net margin — 34.1% vs -1.7%, a 35.8% gap on every dollar of revenue. Over the past eight quarters, SouthState Bank Corp's revenue compounded faster (37.4% CAGR vs 11.1%).

United Surgical Partners International, Inc. (USPI) is an American ambulatory care company based in Dallas, Texas. It was founded by Don Steen in 1998.

SouthState Bank, based in Winter Haven, Florida, is an American bank and a subsidiary of SouthState Corporation, a bank holding company. As of May 26, 2025, the company had 371 branches in South Carolina, North Carolina, Georgia, Florida, Alabama, Virginia, Colorado and Texas.

SGRY vs SSB — Head-to-Head

Bigger by revenue
SGRY
SGRY
1.3× larger
SGRY
$885.0M
$661.7M
SSB
Higher net margin
SSB
SSB
35.8% more per $
SSB
34.1%
-1.7%
SGRY
Faster 2-yr revenue CAGR
SSB
SSB
Annualised
SSB
37.4%
11.1%
SGRY

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
SGRY
SGRY
SSB
SSB
Revenue
$885.0M
$661.7M
Net Profit
$-15.0M
$225.8M
Gross Margin
Operating Margin
12.5%
15.1%
Net Margin
-1.7%
34.1%
Revenue YoY
2.4%
Net Profit YoY
86.2%
153.5%
EPS (diluted)
$-0.11
$2.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SGRY
SGRY
SSB
SSB
Q1 26
$661.7M
Q4 25
$885.0M
$581.1M
Q3 25
$821.5M
$599.7M
Q2 25
$826.2M
$577.9M
Q1 25
$776.0M
$544.5M
Q4 24
$864.4M
$369.8M
Q3 24
$770.4M
$351.5M
Q2 24
$762.1M
$350.3M
Net Profit
SGRY
SGRY
SSB
SSB
Q1 26
$225.8M
Q4 25
$-15.0M
$247.7M
Q3 25
$-22.7M
$246.6M
Q2 25
$-2.5M
$215.2M
Q1 25
$-37.7M
$89.1M
Q4 24
$-108.5M
$144.2M
Q3 24
$-31.7M
$143.2M
Q2 24
$-15.5M
$132.4M
Operating Margin
SGRY
SGRY
SSB
SSB
Q1 26
15.1%
Q4 25
12.5%
54.3%
Q3 25
12.9%
53.6%
Q2 25
13.5%
48.8%
Q1 25
8.0%
22.3%
Q4 24
14.7%
50.7%
Q3 24
7.9%
53.1%
Q2 24
11.1%
49.3%
Net Margin
SGRY
SGRY
SSB
SSB
Q1 26
34.1%
Q4 25
-1.7%
42.6%
Q3 25
-2.8%
41.1%
Q2 25
-0.3%
37.2%
Q1 25
-4.9%
16.4%
Q4 24
-12.6%
39.0%
Q3 24
-4.1%
40.7%
Q2 24
-2.0%
37.8%
EPS (diluted)
SGRY
SGRY
SSB
SSB
Q1 26
$2.28
Q4 25
$-0.11
$2.47
Q3 25
$-0.18
$2.42
Q2 25
$-0.02
$2.11
Q1 25
$-0.30
$0.87
Q4 24
$-0.86
$1.88
Q3 24
$-0.25
$1.86
Q2 24
$-0.12
$1.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SGRY
SGRY
SSB
SSB
Cash + ST InvestmentsLiquidity on hand
$239.9M
$2.9B
Total DebtLower is stronger
$3.6B
Stockholders' EquityBook value
$1.7B
$9.0B
Total Assets
$8.1B
$68.0B
Debt / EquityLower = less leverage
2.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SGRY
SGRY
SSB
SSB
Q1 26
$2.9B
Q4 25
$239.9M
Q3 25
$203.4M
Q2 25
$250.1M
Q1 25
$229.3M
Q4 24
$269.5M
Q3 24
$221.8M
Q2 24
$213.5M
Total Debt
SGRY
SGRY
SSB
SSB
Q1 26
Q4 25
$3.6B
Q3 25
$3.5B
Q2 25
$3.5B
Q1 25
$3.4B
Q4 24
$3.3B
Q3 24
$3.1B
Q2 24
$3.0B
Stockholders' Equity
SGRY
SGRY
SSB
SSB
Q1 26
$9.0B
Q4 25
$1.7B
$9.1B
Q3 25
$1.7B
$9.0B
Q2 25
$1.7B
$8.8B
Q1 25
$1.7B
$8.6B
Q4 24
$1.8B
$5.9B
Q3 24
$1.9B
$5.9B
Q2 24
$2.0B
$5.7B
Total Assets
SGRY
SGRY
SSB
SSB
Q1 26
$68.0B
Q4 25
$8.1B
$67.2B
Q3 25
$7.9B
$66.0B
Q2 25
$8.0B
$65.9B
Q1 25
$7.9B
$65.1B
Q4 24
$7.9B
$46.4B
Q3 24
$7.5B
$46.1B
Q2 24
$7.5B
$45.5B
Debt / Equity
SGRY
SGRY
SSB
SSB
Q1 26
Q4 25
2.10×
Q3 25
2.00×
Q2 25
1.98×
Q1 25
1.98×
Q4 24
1.83×
Q3 24
1.63×
Q2 24
1.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SGRY
SGRY
SSB
SSB
Operating Cash FlowLast quarter
$103.4M
Free Cash FlowOCF − Capex
$90.6M
FCF MarginFCF / Revenue
10.2%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$195.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SGRY
SGRY
SSB
SSB
Q1 26
Q4 25
$103.4M
$232.1M
Q3 25
$83.6M
$122.4M
Q2 25
$81.3M
$72.6M
Q1 25
$6.0M
$-126.3M
Q4 24
$111.4M
$354.3M
Q3 24
$65.2M
$-246.8M
Q2 24
$82.8M
$126.8M
Free Cash Flow
SGRY
SGRY
SSB
SSB
Q1 26
Q4 25
$90.6M
$215.5M
Q3 25
$63.8M
$101.7M
Q2 25
$57.9M
$52.5M
Q1 25
$-16.7M
$-139.1M
Q4 24
$89.1M
$340.9M
Q3 24
$45.0M
$-254.2M
Q2 24
$55.9M
$117.3M
FCF Margin
SGRY
SGRY
SSB
SSB
Q1 26
Q4 25
10.2%
37.1%
Q3 25
7.8%
17.0%
Q2 25
7.0%
9.1%
Q1 25
-2.2%
-25.5%
Q4 24
10.3%
92.2%
Q3 24
5.8%
-72.3%
Q2 24
7.3%
33.5%
Capex Intensity
SGRY
SGRY
SSB
SSB
Q1 26
Q4 25
1.4%
2.9%
Q3 25
2.4%
3.5%
Q2 25
2.8%
3.5%
Q1 25
2.9%
2.4%
Q4 24
2.6%
3.6%
Q3 24
2.6%
2.1%
Q2 24
3.5%
2.7%
Cash Conversion
SGRY
SGRY
SSB
SSB
Q1 26
Q4 25
0.94×
Q3 25
0.50×
Q2 25
0.34×
Q1 25
-1.42×
Q4 24
2.46×
Q3 24
-1.72×
Q2 24
0.96×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SGRY
SGRY

Private Insurance$460.5M52%
Government Revenue$368.6M42%
Other$19.8M2%
Self Pay Revenue$19.6M2%
Other Patient Service Revenue Sources$16.5M2%

SSB
SSB

Net Interest Income$561.6M85%
Noninterest Income$100.1M15%

Related Comparisons